Citation Impact
Citing Papers
Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases
2011 Standout
A DNA-binding Molecule Targeting the Adaptive Hypoxic Response in Multiple Myeloma Has Potent Antitumor Activity
2016
The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti–PD-1 antibody
2010
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy
2015 StandoutScience
Jinx , an MCMV susceptibility phenotype caused by disruption of Unc13d : a mouse model of type 3 familial hemophagocytic lymphohistiocytosis
2007 StandoutNobel
Conserved N-terminal cysteine dioxygenases transduce responses to hypoxia in animals and plants
2019 StandoutScienceNobel
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
2014 StandoutNobel
Pharmacologic Targeting of Hypoxia-Inducible Factors
2019 StandoutNobel
Cancer–stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis
2012 StandoutNobel
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
2017 StandoutNature
T Regulatory Cells Support Plasma Cell Populations in the Bone Marrow
2017 StandoutNobel
Cancer stem cells and hypoxia-inducible factors (Review)
2018
The regulation of IL-10 production by immune cells
2010 Standout
Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells
2008
The neural basis of drug craving: An incentive-sensitization theory of addiction
1993 Standout
Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration
1995 StandoutNobel
Post-transcriptional control of cytokine production
2008
Cancer to bone: a fatal attraction
2011 Standout
Facilitation of sexual behaviors in the male rat associated with Intra-VTA injections of opiates
1990
Effect of the platelet‐activating factor antagonist, TCV‐309, and the cyclo‐oxygenase inhibitor, ibuprofen, on the haemodynamic changes in canine experimental endotoxic shock
1993 StandoutNobel
Tumor-Associated Macrophages: From Mechanisms to Therapy
2014 Standout
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
2006 Standout
CXCL12-CXCR4 Engagement Is Required for Migration of Cutaneous Dendritic Cells
2007
Candidate Serological Biomarkers for Cancer Identified from the Secretomes of 23 Cancer Cell Lines and the Human Protein Atlas
2010
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Antibody therapy of cancer
2012 Standout
The hypoxic tumor microenvironment: A driving force for breast cancer progression
2015 StandoutNobel
Reprogramming of vascular smooth muscle α-actin gene expression as an early indicator of dysfunctional remodeling following heart transplant
2002
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Regulation of Coronary Blood Flow During Exercise
2008
A myocardial lineage derives from Tbx18 epicardial cells
2008 StandoutNature
IL-6 in Inflammation, Immunity, and Disease
2014 Standout
Targeting apoptosis in cancer therapy
2020 Standout
Characterization of Prostaglandin H Synthase 2 Deficient Mice and Implications for Mechanisms of NSAID Action
1997 StandoutNobel
Hypoxia and TGF-β Drive Breast Cancer Bone Metastases through Parallel Signaling Pathways in Tumor Cells and the Bone Microenvironment
2009
Nonsteroidal Antiinflammatory Drugs — Differences and Similarities
1991
An Slfn2 mutation causes lymphoid and myeloid immunodeficiency due to loss of immune cell quiescence
2010 StandoutNobel
Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy
2018 StandoutNobel
Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention
2003
Genetic control of innate immune responses against cytomegalovirus: MCMV meets its match
2002
Mitigation of cardiovascular toxicity in a series of CSF-1R inhibitors, and the identification of AZD7507
2013
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-1 and receptor-2 agonists for cancer therapy
2009
Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
2013 Standout
Post-transcriptional regulons coordinate the initiation and resolution of inflammation
2009
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
1995 StandoutNobel
Antimicrobial reactive oxygen and nitrogen species: concepts and controversies
2004 Standout
Structure and signalling in the IL-17 receptor family
2009 Standout
EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection
2016 StandoutNobel
Genetic dissection of innate immunity to infection: the mouse cytomegalovirus model
2004 StandoutNobel
A multi-targeted approach to treating bone metastases
2014
ER stress-induced cell death mechanisms
2013 Standout
The role of MicroRNAs in human cancer
2016 Standout
Hypoxia-inducible factor 1 mediates TAZ expression and nuclear localization to induce the breast cancer stem cell phenotype
2014 StandoutNobel
NK CELL RECOGNITION
2004 Standout
Osteoprotegerin Inhibits Vascular Calcification Without Affecting Atherosclerosis in ldlr (−/−) Mice
2008
Transgenic Expression of the Activating Natural Killer Receptor Ly49H Confers Resistance to Cytomegalovirus in Genetically Susceptible Mice
2003
Utilitarianism and horizontal equity
1982 StandoutNobel
On the theory of tax reform
1976
Targeting the bone marrow microenvironment in multiple myeloma
2014
Training and Innovation in an Imperfect Labour Market
1997 StandoutNobel
THE INCOME TAX AND CHARITABLE CONTRIBUTIONS: PART I—AGGREGATE AND DISTRIBUTIONAL EFFECTS
1975
More on Rawlsian Optimal Income Taxation: A Complementary Note on E. S. Phelps's "Taxation of Wage Income for Economic Justice"*
1977
A Rudimentary Random-Matching Model with Divisible Money and Prices
1998
Phase I Trial and Pharmacokinetic Study of Lexatumumab in Pediatric Patients With Solid Tumors
2012
The concept of optimal taxation in the overlapping-generations model of capital and wealth
1979 StandoutNobel
Interferon-Stimulated Genes: A Complex Web of Host Defenses
2014 StandoutNobel
Hypoxia promotes IL-32 expression in myeloma cells, and high expression is associated with poor survival and bone loss
2017
Comment on "Search, Money, and Capital: A Neoclassical Dichotomy"
2003 StandoutNobel
Preferential venoconstriction by cyclooxygenase inhibition in vivo without attenuation of nitroglycerin venodilation.
1988
Of Mice and Not Men: Differences between Mouse and Human Immunology
2004 Standout
Impure Altruism and Donations to Public Goods: A Theory of Warm-Glow Giving
1990 Standout
Applications of Palladium-Catalyzed C–N Cross-Coupling Reactions
2016 Standout
Tax incentives and charitable contributions in the United States
1976
GENETIC ANALYSIS OF HOST RESISTANCE: Toll-Like Receptor Signaling and Immunity at Large
2006 StandoutNobel
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Identification of Toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicing
2012
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Multiple Expectational Equilibria under Monopolistic Competition
1988
The Financial Accelerator and the Flight to Quality
1996 StandoutNobel
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1
2014
Vascular Calcification
2008 Standout
Gene Expression Profiling Provides Insight into the Pathophysiology of Chronic Granulomatous Disease
2004
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Works of Peter Diamond being referenced
Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancer
2009
An Example of Rational Expectations Business Cycles in Search Equilibrium
1989
Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells
2009
HIF-2α Promotes Dissemination of Plasma Cells in Multiple Myeloma by Regulating CXCL12/CXCR4 and CCR1
2017
The emerging role of hypoxia, HIF-1 and HIF-2 in multiple myeloma
2011
Cold Shock Domain Proteins Repress Transcription from the GM-CSF Promoter
1996
Osteoprotegerin (OPG) is localized to the Weibel‐Palade bodies of human vascular endothelial cells and is physically associated with von Willebrand factor
2005
A multi‐protein complex containing cold shock domain (Y‐box) and polypyrimidine tract binding proteins forms on the vascular endothelial growth factor mRNA
2004
An Ordered Array of Cold Shock Domain Repressor Elements across Tumor Necrosis Factor-responsive Elements of the Granulocyte-Macrophage Colony-stimulating Factor Promoter
2000
Targeted Disruption of the CXCL12/CXCR4 Axis Inhibits Osteolysis in a Murine Model of Myeloma-Associated Bone Loss
2009
Inventories and Money Holdings in a Search Economy
1990
The tyrosine kinase inhibitor dasatinib dysregulates bone remodeling through inhibition of osteoclasts in vivo
2010
Elevated Serum Levels of Stromal-Derived Factor-1α Are Associated with Increased Osteoclast Activity and Osteolytic Bone Disease in Multiple Myeloma Patients
2005
RNA Destabilization by the Granulocyte Colony-Stimulating Factor Stem-Loop Destabilizing Element Involves a Single Stem-Loop That Promotes Deadenylation
2002
Effects of indomethacin on coronary hemodynamics, myocardial metabolism and anginal threshold in coronary artery disease
1986
Inhibition of mating by naloxone or morphine in recently castrated, but not intact male rats
1985
Federal Tax Policy.
1967
Apomab, a fully human agonistic DR5 monoclonal antibody inhibits tumour growth and osteolysis in murine models of breast cancer development and progression
2009